EE219 Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction
Abstract
Authors
A. Rane R.N. Nechi M. Imam C.R. Zoni C. Ndikumukiza I. Karaye I. Yunusa A. Alanazi
A. Rane R.N. Nechi M. Imam C.R. Zoni C. Ndikumukiza I. Karaye I. Yunusa A. Alanazi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now